Replies to post #210759 on Biotech Values

[mcbio]

I would suggest ABT for that role. ABT has a big business in China not only in pharmaceuticals (branded generics), but also in medical devices, diagnostics, and nutrition products.

Duly noted. Has ABT talked much about expectations for growth in China over the coming years?